(Q43142515)

14 November 2017

title

Effects of renin-angiotensin system blockade on islet function in diabetic rats (English)

1 reference

14 November 2017

Yuan L

1

1 reference

14 November 2017

Li X

series ordinal

2

1 reference

14 November 2017

Xu GL

series ordinal

3

1 reference

14 November 2017

Qi CJ

series ordinal

4

1 reference

14 November 2017

publication date

1 January 2010

1 reference

Journal of Endocrinological Investigation

14 November 2017

published in

1 reference

14 November 2017

volume

33

1 reference

14 November 2017

issue

1

1 reference

14 November 2017

page(s)

13-19

1 reference

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Cytokines and nitric oxide in islet inflammation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Oxidative stress and pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346544

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

21 January 2018

1 reference

12 December 2020

Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta

1 reference

12 December 2020

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials)

1 reference

12 December 2020

The tissue renin-angiotensin system in human pancreas

1 reference

12 December 2020

Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate

1 reference

12 December 2020

Eprosartan dual action offers clinical benefit for elderly and overweight hypertensives

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346544

1 reference

Dimensions Publication ID

14 November 2017

1049618960

0 references

1 reference